Palouse Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,757
| Closed | -$2.42M | – | 81 |
|
|
2022
Q3 | $2.42M | Sell |
10,757
-315
| -3% | -$76.4K | 1.38% | 34 |
|
|
2022
Q2 | $2.69M | Sell |
11,072
-4,679
| -30% | -$1.15M | 1.34% | 35 |
|
|
2022
Q1 | $3.81M | Sell |
15,751
-197
| -1% | -$45.3K | 1.68% | 21 |
|
|
2021
Q4 | $3.59M | Sell |
15,948
-231
| -1% | -$48.8K | 1.53% | 25 |
|
|
2021
Q3 | $3.44M | Sell |
16,179
-463
| -3% | -$107K | 1.53% | 22 |
|
|
2021
Q2 | $4.06M | Sell |
16,642
-76
| -0.5% | -$18.7K | 1.77% | 18 |
|
|
2021
Q1 | $4.16M | Sell |
16,718
-347
| -2% | -$82.8K | 1.83% | 23 |
|
|
2020
Q4 | $3.92M | Sell |
17,065
-1,814
| -10% | -$418K | 2.08% | 15 |
|
|
2020
Q3 | $4.8M | Sell |
18,879
-4,192
| -18% | -$1.04M | 2.69% | 4 |
|
|
2020
Q2 | $5.44M | Sell |
23,071
-855
| -4% | -$195K | 2.87% | 5 |
|
|
2020
Q1 | $4.85M | Buy |
23,926
+3,015
| +14% | +$659K | 2.87% | 8 |
|
|
2019
Q4 | $5.04M | Sell |
20,911
-1,828
| -8% | -$403K | 1.91% | 27 |
|
|
2019
Q3 | $4.4M | Buy |
22,739
+31
| +0.1% | +$5.95K | 1.63% | 28 |
|
|
2019
Q2 | $4.18M | Buy |
+22,708
| New | +$4.07M | 1.51% | 29 |
|
|
2018
Q3 | – | Sell |
-33,865
| Closed | -$6.25M | – | 107 |
|
|
2018
Q2 | $6.25M | Sell |
33,865
-441
| -1% | -$78K | 2.12% | 15 |
|
|
2018
Q1 | $5.85M | Buy |
34,306
+1,722
| +5% | +$316K | 1.95% | 19 |
|
|
2017
Q4 | $5.67M | Sell |
32,584
-332
| -1% | -$58.8K | 1.92% | 21 |
|
|
2017
Q3 | $6.14M | Sell |
32,916
-418
| -1% | -$74.1K | 2.05% | 13 |
|
|
2017
Q2 | $5.74M | Sell |
33,334
-171
| -0.5% | -$27.8K | 2.09% | 12 |
|
|
2017
Q1 | $5.5M | Buy |
33,505
+2,582
| +8% | +$429K | 2.09% | 15 |
|
|
2016
Q4 | $4.52M | Sell |
30,923
-2,851
| -8% | -$429K | 1.85% | 17 |
|
|
2016
Q3 | $5.63M | Sell |
33,774
-535
| -2% | -$90.5K | 2.4% | 11 |
|
|
2016
Q2 | $5.22M | Buy |
+34,309
| New | +$5.33M | 2.12% | 14 |
|
|
2014
Q4 | – | Sell |
-36,228
| Closed | -$5.09M | – | 125 |
|
|
2014
Q3 | $5.09M | Sell |
36,228
-742
| -2% | -$96.9K | 1.94% | 10 |
|
|
2014
Q2 | $4.38M | Buy |
36,970
+2,830
| +8% | +$328K | 1.62% | 17 |
|
|
2014
Q1 | $4.21M | Sell |
34,140
-705
| -2% | -$85.5K | 1.58% | 21 |
|
|
2013
Q4 | $3.98M | Sell |
34,845
-215
| -0.6% | -$24.5K | 1.52% | 27 |
|
|
2013
Q3 | $3.92M | Buy |
35,060
+15
| +0% | +$1.63K | 1.58% | 24 |
|
|
2013
Q2 | $3.46M | Buy |
+35,045
| New | +$3.64M | 1.47% | 31 |
|
Other funds holding AMGN
AWA
Palouse Capital Management's AMGN Position: Q4 2022 in Review
Palouse Capital Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 10,757 shares — an estimated $2.42M sold.
Palouse Capital Management first reported a position in AMGN in Q2 2013 and held it in 29 quarters. The position peaked at $6.25M in Q2 2018. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- Palouse Capital Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
- Palouse Capital Management sold 10,757 Amgen shares in Q4 2022, an estimated $2.42M.
- Palouse Capital Management first reported a position in Amgen in Q2 2013 and held it in 29 quarters.
- Palouse Capital Management's Amgen position peaked at $6.25M in Q2 2018.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on Palouse Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.